# China NMPA Drug Inspection - Hubei Haosun Pharmaceutical Co., Ltd. - Azithromycin granules

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/hubei-haosun-pharmaceutical-co-ltd/f1754d46-82bd-4d46-9bc4-054c23ff20f2/
Source feed: China

> China NMPA drug inspection for Hubei Haosun Pharmaceutical Co., Ltd. published June 01, 2016. Drug: Azithromycin granules. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Shandong Province Drug Quality Bulletin (Issue 5, 2016)
- Company Name: Hubei Haosun Pharmaceutical Co., Ltd.
- Publication Date: 2016-06-01
- Drug Name: Azithromycin granules
- Inspection Finding: Compliant

Company: https://www.globalkeysolutions.net/companies/hubei-haosun-pharmaceutical-co-ltd/a8ee3f4d-8f6b-432f-8452-d04dc31a1eee/